MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
MindImmune Therapeutics has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
MindImmune Therapeutics's investors include Slater Technology Fund, Pfizer Venture Investments, Gates Frontier Fund, Alzheimer's Drug Discovery Foundation, Dolby Family Ventures.
MindImmune Therapeutics is headquartered in Providence, United States.
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
MindImmune Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MindImmune Therapeutics — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/mindimmune-therapeutics. Accessed October 31, 2026.
VCBacked. (2026). MindImmune Therapeutics — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/mindimmune-therapeutics
{{cite web |title=MindImmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mindimmune-therapeutics |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated